Dr. Nitya Alluri
Claim this profileProvidence Portland Medical Center
Expert in Thyroid Cancer
Studies Relapse
28 reported clinical trials
79 drugs studied
About Nitya Alluri
Education:
- Obtained MD from St. George's University School of Medicine in 2015.
- Completed Residency in Internal Medicine at Providence Portland Medical Center, serving as Chief Resident (2018-2019).
Experience:
- Currently practices as an Internal Medicine physician at Providence Portland Medical Center.
Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage I
Stage III
2Relapse
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Nitya Alluri is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Nitya Alluri
Clinical Trial Related1 year of experience running clinical trials · Led 28 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Nitya Alluri has experience with
- Radiation Therapy
- Carboplatin
- Cisplatin
- Nivolumab
- Atezolizumab
- Olaparib
Breakdown of trials Nitya Alluri has run
Thyroid Cancer
Relapse
Stomach Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nitya Alluri specialize in?
Nitya Alluri focuses on Thyroid Cancer and Relapse. In particular, much of their work with Thyroid Cancer has involved Stage IV patients, or patients who are Stage I.
Is Nitya Alluri currently recruiting for clinical trials?
Yes, Nitya Alluri is currently recruiting for 17 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Nitya Alluri has studied deeply?
Yes, Nitya Alluri has studied treatments such as Radiation Therapy, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Nitya Alluri?
Apply for one of the trials that Nitya Alluri is conducting.
What is the office address of Nitya Alluri?
The office of Nitya Alluri is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.